Lada Rasochova, Phd Mba

Lada Rasochova, Phd Mba Email and Phone Number

Founder and CEO @ DERMALA Inc.
San Diego, CA, US
Lada Rasochova, Phd Mba's Location
San Diego, California, United States, United States
About Lada Rasochova, Phd Mba

Experienced business executive with a successful track record of commercializing innovations, launching new products to market, and building new businesses in the pharma, biotech, and consumer sectors. Founder and CEO of DERMALA, a consumer dermatology startup that leverages scientific understanding of the human microbiome and data analytics to develop and launch novel, patented, science-backed, and clinically validated topical treatments and supplements for acne, eczema, and skin health & longevity to market. Before founding DERMALA, I spent more than 15 years in the biotech and pharma industry. I started my career as a Scientist and Group Leader at Mycogen, a biotechnology startup in San Diego that the Dow Chemical Company acquired for $1.2B. I then held various leadership positions at the Dowpharma division of the Dow Chemical Company, including as the R&D Leader of Vaccines and immunotherapies, Director of New Business Development, and other leadership positions responsible for early innovation and partnering. The Dowpharma San Diego was spun out into a venture-funded Pfenex Inc. that went public via an IPO. I then joined the University of California San Diego to build world-class entrepreneurship capabilities at the newly founded business school, the Rady School of Management. At Rady. I founded and was the Managing Director of the Rady Venture Fund (8 investments, 3 exits) and developed an entrepreneurship and venture capital-oriented MBA curriculum. I co-founded and built the California Institute for Innovation and Development/Sulivan Center for Entrepreneurship, StartR accelerator, the incubation program for commercialization of early-stage innovations, and worked with more than 200 technology-driven startups founded by UCSD students and alumni. As a result of my work, the Rady School ranked #4 among the U.S. business schools in entrepreneurship, #1 among the University of California, and #2 in California (after Stanford). I received several awards for my work, including the Athena Pinnacle Award, the Most Innovative Thinkers Award, and multiple San Diego 500 Influential Business Leaders Awards.

Lada Rasochova, Phd Mba's Current Company Details
DERMALA Inc.

Dermala Inc.

View
Founder and CEO
San Diego, CA, US
Website:
dermala.com
Employees:
7
Lada Rasochova, Phd Mba Work Experience Details
  • Dermala Inc.
    Founder And Ceo
    Dermala Inc.
    San Diego, Ca, Us
  • Dermala Inc.
    Founder & Ceo
    Dermala Inc. 2021 - Present
    San Diego, Ca, Us
    DERMALA Inc. is a San Diego-based consumer dermatology startup leveraging microbiome science and data analytics to develop novel, clinically validated, and patented topical treatments and oral supplements for acne, eczema, and other skin conditions. For more information, visit www.dermala.com.
  • Dermala Inc.
    Founder
    Dermala Inc. 2015 - 2021
    San Diego, Ca, Us
    As the Founder of DERMALA, I led the early-stage research and transition of innovative scientific concepts to proof of concept and practical applications.
  • Astia
    Advisor & Member, Astia Angels
    Astia 2012 - Present
    San Francisco, Ca, Us
    Astia actively identifies women-led ventures and makes investments in the most promising companies.
  • Rady School Of Management
    Founder & Managing Director, Rady Venture Fund
    Rady School Of Management 2010 - 2021
    La Jolla, Ca, Us
    Founder and Managing Director of the Rady Venture Fund, a student-assisted venture capital fund that invests in innovative, seed, and early-stage science and technology startups while providing hands-on education to students in deal sourcing, diligence, investments, portfolio management, and exits. Oversaw 3 exits - (1) IPO, (2) M&A, and (3) secondary transaction.
  • Rady School Of Management
    Founder & Executive Director, Startr Accelerator
    Rady School Of Management 2012 - 2020
    La Jolla, Ca, Us
    Founder of StartR Accelerator, an early-stage incubator that provides students, alumni, and researchers with robust training, mentorship, and an ecosystem of resources to advance entrepreneurial ideas from concepts to market. StartR has yielded over 100 startup companies that have raised over $100M in ten years.
  • Rady School Of Management
    Founder & Executive Director, Ciid/Sullivan Center For Entrepreneurship And Innovation
    Rady School Of Management 2010 - 2020
    La Jolla, Ca, Us
    Founder of the California Institute for Innovation and Development (CIID)/Sulivan Center for Entrepreneurship and Innovation to empower students and alumni with programs, experiences, networks, and a mindset to embrace disruption as an opportunity to identify needs and innovative solutions to problems and translate science and technology-driven innovations from concepts to market.
  • University Of California San Diego
    Board Member - Strategic Advisor - University Of California Discovery Fellow
    University Of California San Diego 2009 - 2020
    La Jolla, Ca, Us
    Executive Council Member, Qualcomm Institute, 2017 - 2020Executive Committee Member, Center for Drug Discovery Innovation, 2015 - 2019Advisory Board Member, NSF Center for Aerosol Impacts on Chemistry of the Environment, 2013-2018Affiliate Member, Center for Microbiome Innovation, 2016 - 2020Member, Clinical and Translational Research Institute, 2016 - 2019UC Discovery Fellow, 2009-2010
  • Plug And Play Tech Center
    Advisor, Plug And Play San Diego
    Plug And Play Tech Center 2012 - 2017
    Sunnyvale, Ca, Us
  • Xprize
    Judge, Nokia Sensing Xchallenge
    Xprize 2014 - 2016
    Culver City, Ca, Us
  • Jadus Biosciences
    Founder & Ceo
    Jadus Biosciences 2008 - 2010
    Jadus BioSciences, a diagnostic company, developed SEL Express Ultra and SEL Express HTP for fast and accurate detection of Salmonella, E. coli, and Listeria pathogens in produce and packaged foods. Food-borne disease outbreaks cause 76 M illnesses, 325,000 hospitalizations and 5,000 deaths in the U.S. per year. Jadus BioSciences is the winner of the 2008 Medical Engineering Innovation Challenge competition at the University of Southern California.
  • Dow
    Director, New Business Development - Dowpharma
    Dow 1999 - 2010
    Midland, Michigan, Us
    Built and managed the Human Vaccine Division of the Dow Chemical Company. Built and led an R&D team of 20+ scientists. As a member of the Intellectual Capital Management Team, led the development and implementation of IP strategy. Identified new business opportunities and conducted technology due diligence and market evaluations, competitor assessments, and financial analysis. Advanced 5 human vaccines and several immunotherapeutic candidates through preclinical development including proof of concept studies in non-human primates, advanced two of the candidates to human clinical trials. Negotiated R&D and commercial licenses, consulting agreements, outsourcing agreements, and external contracts, and managed technology transfer and academic collaborations. Led the development and implementation of novel microbial, viral, and plant production systems for vaccine antigens. Generated revenues - closed several multi-million dollar vaccine antigen production contracts with outside parties including the largest Dowpharma customer project at the time. Awards & Recognitions:o Innovative Scientific Contributor, The Dow Chemical Company, 2006, 2007, 2008
  • Dow
    R&D Leader, Vaccines And Immunotherapies - Dowpharma
    Dow 2003 - 2006
    Midland, Michigan, Us
    Launched an internal product development effort in human vaccines and immunotherapeutics. Won $10 M award from NIH to develop novel vaccines and served as Dow Principal Investigator. Built and managed a core vaccine team of 8 scientists and cross-functional collaborations across Dow. Established connections with internationally recognized vaccine experts at academic institutions. Built relationship with CROs, DHHS, DOD, NIH, CDC, DARPA, and USAMRIID. Developed new IP and preclinical data for 5 novel vaccine candidates. Awards & Recognitions:o Innovative Scientific Contributor, The Dow Chemical Company, 2004, 2005, o Recognition Award for Significant Accomplishments in the development of new cutting-edge technologies for the production of human vaccine candidates, The Dow Chemical Company, 2005o 3 Carat Special Recognition Award, The Dow Chemical Company, 2006 o 2 Carat Special Recognition Award, The Dow Chemical Company, 2006
  • Dow
    Program Manager, New Technology Acquisition - Dowpharma
    Dow 2001 - 2003
    Midland, Michigan, Us
    Acquired an innovative vaccine startup in Great Britain and led the technology due diligence, post-acquisition technology transfer, and technology integration in-house. Licensed multiple novel technologies from US academic institutions. Developed and implemented an IP strategy for human vaccines. Launched the human vaccine program at Dow.Awards & Recognitions:o Special Recognition Award for Outstanding Contributions, The Dow Chemical Company, 2001 o Innovative Scientific Contributor, The Dow Chemical Company, 2001, 2002
  • Dow
    Group Leader, Virology & Novel Vaccines
    Dow 1999 - 2001
    Midland, Michigan, Us
    Developed a novel vaccine antigen display system based on virus-like particles. Awards & Recognitions:o Innovative Scientific Contributor, The Dow Chemical Company, 2000
  • Mycogen
    Scientist, Virology & Novel Expression Systems
    Mycogen 1998 - 1999
    Developed a novel viral vector-based gene expression system and proprietary technology applications. Dow Chemical acquired Mycogen for $1.2B.

Lada Rasochova, Phd Mba Skills

Biotechnology Start Ups Commercialization Entrepreneurship Strategy Drug Development Genomics Strategic Planning Leadership Vaccines Venture Capital Lifesciences Technology Transfer Management Licensing R&d Medical Devices Cross Functional Team Leadership Drug Discovery Molecular Biology Biochemistry Program Management Angel Investing Biopharmaceuticals Product Development Science Protein Chemistry Public Speaking Clinical Development Marketing Strategy Data Analysis Pharmaceutical Industry New Business Development Regulatory Affairs Fda Assay Development Cell Culture Cell Biology Hardware Diagnostics Bioinformatics Genetics Immunology Infectious Diseases Clinical Trials Virology Cancer Oncology Microbiology Neuroscience Cell

Lada Rasochova, Phd Mba Education Details

  • University Of California, San Diego - Rady School Of Management
    University Of California, San Diego - Rady School Of Management
    Technology Commercialization
  • University Of Wisconsin-Madison
    University Of Wisconsin-Madison
    Virology
  • Iowa State University
    Iowa State University
    Virology
  • Uc San Diego
    Uc San Diego
    Clinical Trials Management
  • Czech University Of Life Sciences, Prague, Czech Republic
    Czech University Of Life Sciences, Prague, Czech Republic
    Genetics

Frequently Asked Questions about Lada Rasochova, Phd Mba

What company does Lada Rasochova, Phd Mba work for?

Lada Rasochova, Phd Mba works for Dermala Inc.

What is Lada Rasochova, Phd Mba's role at the current company?

Lada Rasochova, Phd Mba's current role is Founder and CEO.

What is Lada Rasochova, Phd Mba's email address?

Lada Rasochova, Phd Mba's email address is ra****@****hoo.com

What is Lada Rasochova, Phd Mba's direct phone number?

Lada Rasochova, Phd Mba's direct phone number is +185852*****

What schools did Lada Rasochova, Phd Mba attend?

Lada Rasochova, Phd Mba attended University Of California, San Diego - Rady School Of Management, University Of Wisconsin-Madison, Iowa State University, Uc San Diego, Czech University Of Life Sciences, Prague, Czech Republic.

What are some of Lada Rasochova, Phd Mba's interests?

Lada Rasochova, Phd Mba has interest in Mobile, Lean Startups, Health Care, Silicon Valley, Mobile Health, Business, Angel Investing, Clean Technology, High Tech, Startup Advice And Strategy.

What skills is Lada Rasochova, Phd Mba known for?

Lada Rasochova, Phd Mba has skills like Biotechnology, Start Ups, Commercialization, Entrepreneurship, Strategy, Drug Development, Genomics, Strategic Planning, Leadership, Vaccines, Venture Capital, Lifesciences.

Who are Lada Rasochova, Phd Mba's colleagues?

Lada Rasochova, Phd Mba's colleagues are Michelle Kem, Alex Alim, Spencer Levine.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.